CN-105 | Interleukin Related interleukin-related.com

Product Name :
CN-105

Search keywords :
ApoE

drugId :
null

Target Vo:
Apolipoprotein E

Target Vo Short Name :
APOE

Moa_Name:
Apolipoprotein E agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Aegiscn Llc

Active Company_Name :
Aegiscn Llc

Active Indication_Name:
Cerebral Hemorrhage

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Nipocalimab web
p38 alpha/MAPK14 Antibody custom synthesis
LAMP2 Antibody (YA713): LAMP2 Antibody (YA713) is a non-conjugated and Mouse origined monoclonal antibody about 45 kDa, targeting to LAMP2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts